Health care pharmaceutical companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Grifols has the lowest figure of the 50 health care pharmaceutical companies ranked by P/S ratio, at 0.7, followed by Viatris (1.6) and GSK (2.2). Figures as of 20 Nov 2026, 01:52 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 50
- Lowest
- Grifols0.7
- Median
- 6.7
- Combined market value
- THB 168.47T
- Countries
- 10
- Not ranked
- 11no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | GrifolsGRFS · Health Care | 0.7 | THB 189.5B | THB 278.39 | 3.19% down | 0% up | ||
| 2 | ViatrisVTRS · Health Care | 1.6 | THB 773.8B | THB 674.93 | 1.97% down | 99% up | ||
| 3 | GSKGSK · Health Care | 2.2 | THB 3.25T | THB 1,623.49 | 1.56% down | 5% up | ||
| 4 | SanofiSNY · Health Care | 2.3 | THB 3.75T | THB 1,563.74 | 2.25% down | 4% down | ||
| 5 | Takeda PharmaceuticalTAK · Health Care | 2.4 | THB 2.32T | THB 726.87 | 0.66% up | 51% up | ||
| 6 | Amneal PharmaceuticalsAMRX · Health Care | 2.5 | THB 253B | THB 726.19 | 2.24% down | 90% up | ||
| 7 | Bristol-Myers SquibbBMY · Health Care | 2.5 | THB 4.05T | THB 1,980.64 | 2.05% down | 30% up | ||
| 8 | PfizerPFE · Health Care | 2.5 | THB 5.33T | THB 934.98 | 1.85% down | 15% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.6 | THB 1.53T | THB 1,308.43 | 8.74% down | 74% up | ||
| 10 | Elanco Animal HealthELAN · Health Care | 2.8 | THB 446.1B | THB 892.55 | 1.54% down | 26% up | ||
| 11 | PTC TherapeuticsPTCT · Health Care | 2.8 | THB 165.4B | THB 1,980.13 | 3.16% down | 21% down | ||
| 12 | Legend BiotechLEGN · Health Care | 3.0 | THB 106B | THB 546.60 | 0.92% down | 41% down | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | THB 419.7B | THB 503.48 | 1.00% down | 8% up | ||
| 14 | ZoetisZTS · Health Care | 3.5 | THB 1.11T | THB 2,742.82 | 5.59% down | 26% down | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | THB 515.3B | THB 8,027.48 | 4.57% down | 41% up | ||
| 16 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | THB 403.9B | THB 2,085.21 | 0.02% down | 17% up | ||
| 17 | Novo NordiskNVO · Health Care | 3.7 | THB 5.82T | THB 1,319.64 | 1.42% down | 17% down | ||
| 18 | Abbott LaboratoriesABT · Health Care | 4.1 | THB 6.11T | THB 3,526.39 | 0.58% down | 16% down | ||
| 19 | AstraZenecaAZN · Health Care | 4.6 | THB 9.24T | THB 5,955.17 | 1.87% down | 1% up | ||
| 20 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | THB 153.9B | THB 924.12 | 0.62% down | 63% down | ||
| 21 | Merck & CoMRK · Health Care | 5.0 | THB 11.12T | THB 4,508.90 | 3.61% down | 45% up | ||
| 22 | NovartisNVS · Health Care | 5.2 | THB 9.7T | THB 5,133.92 | 2.57% down | 25% up | ||
| 23 | AlkermesALKS · Health Care | 5.3 | THB 263.5B | THB 1,567.81 | 1.43% down | 66% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | THB 672.2B | THB 5,018.49 | 1.06% down | 66% down | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | THB 3.24T | THB 31,347.39 | 2.35% down | 28% up | ||
| 26 | Johnson & JohnsonJNJ · Health Care | 6.8 | THB 21.83T | THB 9,069.40 | 2.04% down | 34% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | THB 209.5B | THB 1,481.92 | 1.25% up | 13% up | ||
| 28 | United TherapeuticsUTHR · Health Care | 7.5 | THB 808.4B | THB 18,981.45 | 3.16% down | 22% up | ||
| 29 | AbbVieABBV · Health Care | 8.2 | THB 17.02T | THB 9,626.18 | 0.86% down | 25% up | ||
| 30 | GenmabGMAB · Health Care | 8.5 | THB 1.07T | THB 1,743.33 | 0.75% up | 70% up | ||
| 31 | BeOne MedicinesONC · Health Care | 8.5 | THB 1.55T | THB 13,569.82 | 0.97% down | 16% up | ||
| 32 | Corcept TherapeuticsCORT · Health Care | 9.3 | THB 241.4B | THB 2,206.07 | 4.15% down | 10% down | ||
| 33 | Travere TherapeuticsTVTX · Health Care | 9.4 | THB 157.4B | THB 1,639.79 | 3.86% down | 45% up | ||
| 34 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | THB 312.9B | THB 13,469.32 | 0.34% down | 27% down | ||
| 35 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | THB 249.5B | THB 3,175.51 | 1.59% down | 129% up | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | THB 4.48T | THB 17,676.41 | 2.94% down | 27% up | ||
| 37 | Axsome TherapeuticsAXSM · Health Care | 11.2 | THB 242.3B | THB 4,606.34 | 1.25% up | 6% down | ||
| 38 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | THB 211.7B | THB 3,242.56 | 3.27% up | 34% up | ||
| 39 | TG TherapeuticsTGTX · Health Care | 15.9 | THB 332.9B | THB 2,202.68 | 1.88% down | 117% up | ||
| 40 | Royalty PharmaRPRX · Health Care | 16.4 | THB 1.32T | THB 2,299.09 | 1.38% down | 79% up | ||
| 41 | Eli LillyLLY · Health Care | 18.5 | THB 40.86T | THB 45,870.52 | 2.29% down | 33% up | ||
| 42 | Ascendis PharmaASND · Health Care | 21.0 | THB 570B | THB 8,689.84 | 5.32% down | 29% up | ||
| 43 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | THB 194.9B | THB 9,741.61 | 3.94% down | 50% up | ||
| 44 | BridgeBio PharmaBBIO · Health Care | 30.3 | THB 517B | THB 2,654.21 | 0.22% up | 21% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | THB 274.9B | THB 3,965.36 | 1.88% down | 18% up | ||
| 46 | InsmedINSM · Health Care | 52.3 | THB 1.08T | THB 4,904.42 | 20.58% up | 40% down | ||
| 47 | CytokineticsCYTK · Health Care | 81.4 | THB 243.4B | THB 1,747.07 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | 176 | THB 274.8B | THB 4,210.48 | 2.47% down | 51% up | ||
| 49 | Dianthus TherapeuticsDNTH · Health Care | 2346 | THB 162.2B | THB 2,879.98 | 1.01% up | 108% up | ||
| 50 | Roivant SciencesROIV · Health Care | 3418 | THB 958.4B | THB 1,322.69 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB). 11 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/S ratio?
Grifols (0.7), Viatris (1.6) and GSK (2.2) have the lowest P/S ratio of the 50 health care pharmaceutical companies ranked here as of 20 Nov 2026, 01:52 UTC.
How many health care pharmaceutical companies are in this ranking?
50 are ranked by P/S ratio. 11 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 50 health care pharmaceutical companies ranked by P/S ratio have a combined market value of THB 168.47T as of 20 Nov 2026, 01:52 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.